Acurx Pharmaceuticals LLC Financial Flexibility Index
Acurx Pharmaceuticals LLC financial flexibility index. Acurx Pharmaceuticals LLC (ACXP) has a Financial Flexibility Index of -0.60x as of June 2026. Free cash flow of $-1.71 Million (operating CF $-1.71 Million minus capex $0.00) represents -1% of total liabilities ($2.83 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Acurx Pharmaceuticals LLC (2019–2025)
Financial flexibility index of Acurx Pharmaceuticals LLC from 2019 to 2025. Historical Financial Flexibility Index trend for Acurx Pharmaceuticals LLC across 7 annual periods. Explore cash flow to debt ratio of Acurx Pharmaceuticals LLC to assess how comfortably operating cash covers total debt obligations.
Acurx Pharmaceuticals LLC Financial Flexibility Index by Year (2019–2025)
Acurx Pharmaceuticals LLC financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Acurx Pharmaceuticals LLC. For the full cash flow conversion analysis, see Acurx Pharmaceuticals LLC operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.80x | $-6.79 Million | $-6.79 Million | $2.42 Million | ▲ +12.4% |
| 2024 | -3.20x | $-10.38 Million | $-10.38 Million | $3.24 Million | ▲ +0.6% |
| 2023 | -3.22x | $-9.80 Million | $-9.80 Million | $3.04 Million | ▲ +11.9% |
| 2022 | -3.66x | $-7.54 Million | $-7.54 Million | $2.06 Million | ▲ +38.4% |
| 2021 | -5.94x | $-5.01 Million | $-5.01 Million | $843.91K | ▲ +7.4% |
| 2020 | -6.42x | $-3.35 Million | $-3.35 Million | $522.43K | ▼ -175.5% |
| 2019 | -2.33x | $-3.99 Million | $-3.99 Million | $1.71 Million | — |